News Updates‎ > ‎

Small Study: Methylphenidate May Increase Attention, Reduce Apathy In Patients With AD

posted Mar 23, 2013, 4:30 PM by Will Martin
Medscape (3/22, Gammon) reports, "Methylphenidate (MPH), a psychostimulant commonly used to treat attention-deficit/hyperactivity disorder (AD/HD), can help improve attention and reduce apathy in patients with Alzheimer's disease (AD)," according to the results of a 60-patient study presented at the American Association for Geriatric Psychiatry's annual meeting. "Interestingly, there was no correlation between attention and apathy in the treated individual - each parameter improved independently." The study's lead author "noted that the reasons for this are not entirely clear."